ZT
ZETAGEN THERAPEUTICS, INC.
SEC filingPharmaceuticals · Syracuse, NY
Amount raised$12.9Msold at filing
Total offering$13M$92K still open
Investors in the raise35count reported to the SEC
FiledNov 12, 2025first sale Oct 31, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Joe C LoyExecutive Officer, Director
Richard C WarburgDirector
Ashok C KaveeshwarDirector
Peter B. FinnExecutive Officer
Nikhil Thakur, MDExecutive Officer, Director
Donald C BrownDirector
Executive officers, directors and promoters as listed on the Form D.